|
FMR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.60069999996815E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04150000004955E-06 |
| Normal-vs-Stage2 |
3.223600E-01 |
| Normal-vs-Stage3 |
5.443700E-02 |
| Normal-vs-Stage4 |
1.395800E-03 |
| Stage1-vs-Stage2 |
2.038400E-01 |
| Stage1-vs-Stage3 |
2.139700E-02 |
| Stage1-vs-Stage4 |
9.218400E-01 |
| Stage2-vs-Stage3 |
9.353000E-01 |
| Stage2-vs-Stage4 |
2.461600E-01 |
| Stage3-vs-Stage4 |
1.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48199999999255E-05 |
| Normal-vs-AfricanAmerican |
5.743500E-03 |
| Normal-vs-Asian |
2.848600E-01 |
| Caucasian-vs-AfricanAmerican |
3.056600E-01 |
| Caucasian-vs-Asian |
7.455800E-01 |
| AfricanAmerican-vs-Asian |
9.269400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.31729999994523E-06 |
| Normal-vs-Female |
1.404220E-02 |
| Male-vs-Female |
3.554100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.617300E-04 |
| Normal-vs-Extreme_Weight |
4.34609999988567E-07 |
| Normal-vs-Obese |
1.203640E-02 |
| Normal-vs-Extreme_Obese |
7.369000E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.146400E-01 |
| Normal_Weight-vs-Obese |
1.591000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.896200E-01 |
| Extreme_Weight-vs-Obese |
1.291620E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.996800E-01 |
| Obese-vs-Extreme_Obese |
1.982750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.918800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.644900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.06549999945705E-07 |
| Normal-vs-Age(81-100Yrs) |
2.515500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.702600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.565700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.756820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.566400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.298000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.348400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.20989999999821E-05 |
| Normal-VS-Type2 PRCC |
2.43169999999404E-05 |
| Normal-VS-KIRP CIMP |
8.483800E-01 |
| Normal-VS-Unclassified PRCC |
2.917000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.608600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.521990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.095400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.177190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.315400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.071200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.628200E-04 |
| Normal-vs-N1 |
4.714000E-02 |
| Normal-vs-N2 |
1.041070E-03 |
| N0-vs-N1 |
2.891800E-01 |
| N0-vs-N2 |
3.168800E-01 |
| N1-vs-N2 |
7.687700E-02 |
|
|
